3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Colorectal Neoplasms
6
Lung Neoplasms
5
Breast Neoplasms
5
Prostatic Neoplasms
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Gastrointestinal Neoplasms
2
Uterine Cervical Neoplasms
1
Support of the Family as a Caregiving System
1
Stomach Neoplasms
1
Sarcoma
1
Quality of Life
1
Pseudomyxoma Peritonei
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Otorhinolaryngologic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Mixed Dementias
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Maxillary Sinus Neoplasms
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Follicular
1
Localized Head and Neck Carcinoma
1
Interventions
Pemetrexed
18
Bevacizumab
9
Spinal Puncture
7
Radiotherapy
7
Specimen Handling
5
Methotrexate
5
Magnetic Resonance Spectroscopy
5
osimertinib
4
aflutinib
4
Trastuzumab
3
Topotecan
3
Temozolomide
3
Dexamethasone
3
trastuzumab deruxtecan
2
pembrolizumab
2
merphos
2
lorlatinib
2
Vitamin B 12
2
Rituximab
2
Radiotherapy, Intensity-Modulated
2
Folic Acid
2
Drug Therapy
2
Cytarabine
2
Cyclophosphamide
2
tucatinib
1
toripalimab
1
sintilimab
1
sacituzumab govitecan
1
pertuzumab
1
peginterferon alfa-2b
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Meningeal Carcinomatosis
×
Referral and Consultation
×
Clear all
NCT05286684
2026-03-18
Exo-LCR
Centre Oscar Lambret
Phase NA
Completed
7 enrolled